HK1036618A1 - 喹啉衍生物 - Google Patents

喹啉衍生物 Download PDF

Info

Publication number
HK1036618A1
HK1036618A1 HK01105489A HK01105489A HK1036618A1 HK 1036618 A1 HK1036618 A1 HK 1036618A1 HK 01105489 A HK01105489 A HK 01105489A HK 01105489 A HK01105489 A HK 01105489A HK 1036618 A1 HK1036618 A1 HK 1036618A1
Authority
HK
Hong Kong
Prior art keywords
ethyl
methyl
propyl
quinoline
iso
Prior art date
Application number
HK01105489A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1036618B (zh
Inventor
Bjork Anders
Jonsson Stig
Fex Tomas
Hedlund Gunnar
Original Assignee
Active Biotech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Active Biotech Ab filed Critical Active Biotech Ab
Publication of HK1036618A1 publication Critical patent/HK1036618A1/zh
Publication of HK1036618B publication Critical patent/HK1036618B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK01105489.6A 1998-04-27 1999-04-26 喹啉衍生物 HK1036618B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9801474A SE9801474D0 (sv) 1998-04-27 1998-04-27 Quinoline Derivatives
SE9801474 1998-04-27
PCT/SE1999/000676 WO1999055678A1 (en) 1998-04-27 1999-04-26 Quinoline derivatives

Publications (2)

Publication Number Publication Date
HK1036618A1 true HK1036618A1 (zh) 2002-01-11
HK1036618B HK1036618B (zh) 2003-04-11

Family

ID=

Also Published As

Publication number Publication date
EE04275B1 (et) 2004-04-15
NO315606B1 (no) 2003-09-29
YU61200A (sh) 2003-07-07
HU227709B1 (en) 2011-12-28
EP1073639A1 (en) 2001-02-07
ID26277A (id) 2000-12-14
IL138160A (en) 2006-04-10
TR200003061T2 (tr) 2001-01-22
JP4045069B2 (ja) 2008-02-13
HUP0102084A3 (en) 2002-12-28
UA60354C2 (uk) 2003-10-15
HRP20000726A2 (en) 2001-04-30
ME00870B (me) 2008-11-28
EP1073639B1 (en) 2002-11-27
BR9909925B1 (pt) 2010-09-21
PT1073639E (pt) 2003-04-30
HUP0102084A2 (hu) 2001-11-28
EE200000613A (et) 2002-04-15
NO20005254D0 (no) 2000-10-19
SE9801474D0 (sv) 1998-04-27
WO1999055678A1 (en) 1999-11-04
BR9909925A (pt) 2001-01-09
OA11547A (en) 2004-05-24
DE69904162D1 (de) 2003-01-09
AU4301399A (en) 1999-11-16
ZA200004601B (en) 2002-02-27
NZ506641A (en) 2002-03-28
JP2002513006A (ja) 2002-05-08
RS50029B (sr) 2008-11-28
CA2329788C (en) 2004-11-23
IS2082B (is) 2006-02-15
DE69904162T2 (de) 2003-08-21
PL343420A1 (en) 2001-08-13
CZ20003849A3 (cs) 2001-03-14
PL190441B1 (pl) 2005-12-30
HRP20000726B1 (hr) 2009-04-30
IL138160A0 (en) 2001-10-31
ES2188242T3 (es) 2003-06-16
AP2000001933A0 (en) 2000-12-31
AP1293A (en) 2004-08-30
CA2329788A1 (en) 1999-11-04
KR100571534B1 (ko) 2006-04-14
CN1298393A (zh) 2001-06-06
CN1113057C (zh) 2003-07-02
CZ297439B6 (cs) 2006-12-13
AU747550B2 (en) 2002-05-16
ATE228505T1 (de) 2002-12-15
IS5615A (is) 2000-08-31
NO20005254L (no) 2000-12-27
RU2197481C2 (ru) 2003-01-27
DK1073639T3 (da) 2003-03-24

Similar Documents

Publication Publication Date Title
EP1073639B1 (en) Quinoline derivatives
US6077851A (en) Quinoline derivatives
EP1095021B1 (en) Quinoline derivatives
US6593343B2 (en) Quinoline derivatives
EP1097139B1 (en) Quinoline derivatives
HK1036618B (zh) 喹啉衍生物
HK1035715B (zh) 喹啉衍生物
MXPA00009954A (en) Quinoline derivatives
KR20010043066A (ko) 퀴놀린 유도체
HK1035716B (zh) 喹啉衍生物
MXPA01000388A (en) Quinoline derivatives

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180426